Form 4: Amgen Director Amy E. Miles Reports Acquisition of 719 Shares of Common Stock

Director Amy E. Miles reports acquiring 719 shares of Amgen common stock on May 31, 2024, through vested Restricted Stock Units (RSUs) under the company's director incentive program.

Summary

• On May 31, 2024, Amy E. Miles, a director of Amgen Inc., acquired 719 shares of common stock.
• The acquisition was made through the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are payable in shares of Amgen's common stock on a one-to-one basis.
• Miles now beneficially owns 3,927 shares of Amgen common stock, including 169 Dividend Equivalents (DEs).
• The DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Sentiment

Score: 7

Explanation: Director acquiring shares is generally a positive signal, indicating confidence in the company. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Director share acquisitions are common and are viewed as a sign of confidence in the company's prospects. This transaction is typical for directors receiving equity compensation.

Comparison to Industry Standards

• Director compensation packages often include stock options, restricted stock units, and other equity-based awards.
• The vesting and acquisition of shares by Amy E. Miles is consistent with standard practices for director compensation in publicly traded companies like Amgen.
• Comparing Amgen's director compensation structure to peers like Johnson & Johnson, Pfizer, and Merck would provide further context.

Stakeholder Impact

• The acquisition of shares by a director can have a slightly positive impact on shareholder sentiment.

Key Dates